Obesity Aggravates Status Epilepticus Through Lipocalin-2-mediated Inflammation and Necroptosis
Neurochemical Research · 2026
DOI: 10.1007/s11064-025-04648-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, 2026. Verfasst von Gwang Seok Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine, Dankook University, Cheonan, 31116, Republic of Korea. Hauptthemen laut MEDLINE: Status Epilepticus, Necroptosis, Obesity, Lipocalin-2. Die Arbeit nennt 59 Literaturangaben. Gefördert von: the National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Obesity is an escalating global health concern associated with numerous comorbidities, including an elevated risk of neurodegenerative disorders. Status epilepticus, characterized by prolonged and recurrent seizures, leads to neuroinflammation and progressive neuronal cell death. Although obesity is recognized as a comorbidity in epilepsy, its mechanistic contribution to SE pathology remains poorly defined. This study investigated the effects of obesity on SE using leptin-deficient ob/ob mice, a well-established model of metabolic dysfunction. Pilocarpine was used to induce SE, and seizure progression was assessed. Compared to wild-type controls, ob/ob mice exhibited significantly reduced latency to seizure onset and a more rapid progression to SE. Fluoro-Jade B staining revealed markedly increased neuronal death in the CA1 and hilus regions of the hippocampus in ob/ob mice. Concurrently, immunofluorescence staining and western blot analysis showed robust astrocyte activation, evidenced by upregulated glial fibrillary acidic protein (GFAP). Obesity also intensified neuroinflammatory signaling, as evidenced by increased levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), along with increased expression of lipocalin-2 (LCN2) and phosphorylated signal transducer and activator of transcription 3(p-STAT3). Furthermore, necroptosis, a regulated form of cell death mediated by mixed lineage kinase domain-like protein (MLKL), was significantly enhanced in ob/ob mice following SE, as indicated by elevated phosphorylated MLKL (p-MLKL) expression. These results suggest that obesity exacerbated seizure susceptibility and amplifies neuroinflammatory and neurodegenerative processes in SE. This work highlights the LCN2-STAT3-MLKL signaling axis as a potential therapeutic target in obesity-associated seizure disorders and offers new insight into the interplay between systemic metabolism and epileptic brain injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, College of Medicine, Dankook University, Cheonan, 31116, Republic of Korea.
- Department of Medical Laser, Graduate School, Dankook University, Cheonan, 31116, Republic of Korea.
- Department of Anatomy, College of Medicine, Gyeongsang National University, Institute of Medical Science, Jinju, 52727, Republic of Korea.
- Department of Anatomy, College of Medicine, Dankook University, Cheonan, 31116, Republic of Korea. mjukim99@dankook.ac.kr.
- Department of Physiology, College of Medicine, Dankook University, Cheonan, 31116, Republic of Korea. heejungkim@dankook.ac.kr.
Förderung
- the National Research Foundation of Korea (NRF)
Zitieren
APA
Lee, G. S., Lee, S. B., Kim, M. H., Roh, G. S., Kim, M. J., & Kim, H. J. (2026). Obesity Aggravates Status Epilepticus Through Lipocalin-2-mediated Inflammation and Necroptosis. Neurochemical Research. https://doi.org/10.1007/s11064-025-04648-9
Vancouver
Lee GS, Lee SB, Kim MH, Roh GS, Kim MJ, Kim HJ. Obesity Aggravates Status Epilepticus Through Lipocalin-2-mediated Inflammation and Necroptosis. Neurochemical Research. 2026. doi:10.1007/s11064-025-04648-9
BibTeX
@article{Lee2026,
author = {Lee, Gwang Seok and Lee, Su Bin and Kim, Mi-Hye and Roh, Gu Seob and Kim, Myeung Ju and Kim, Hee Jung},
title = {Obesity Aggravates Status Epilepticus Through Lipocalin-2-mediated Inflammation and Necroptosis},
journal = {Neurochemical Research},
year = {2026},
doi = {10.1007/s11064-025-04648-9}
}
EUVIMED